For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
34
views
24
references
 Top references
cited by
101
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      1,037
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      U.S. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Breast implant-associated anaplastic large cell lymphoma (ALCL) is a distinctive type of T-cell lymphoma that arises around breast implants. Although rare, all cases with adequate history have involved a textured breast implant. The objective of this study was to determine the U.S. incidence and lifetime prevalence of breast implant-associated ALCL in women with textured breast implants.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: not found
          • Article: not found

          Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant.

          S E J Keech, H J CREECH (1997)
          Article 0 comments Cited 143 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

            Mark W. Clemens, L. Jeffrey Medeiros, Charles Butler … (2016)
            Breast implant-associated anaplastic large-cell lymphoma (BI-ALCL) is a rare type of T-cell lymphoma that arises around breast implants. The optimal management of this disease has not been established. The goal of this study is to evaluate the efficacy of different therapies used in patients with BI-ALCL to determine an optimal treatment approach.
            Article 0 comments Cited 134 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases.

              Grant Carlson, Miles Epstein, James S. House … (2015)
              The first silicone breast implant was inserted in 1962. In 1997, the first case of anaplastic large cell lymphoma (ALCL) in association with a silicone breast implant was reported. The authors reviewed 37 articles in the world literature reporting on 79 patients and collected another 94 unreported cases as of the date of submission. The world literature was reviewed. Missing clinical and laboratory information was solicited from the authors and treating physicians. As several different specialties were involved, information was not in one place. Many (but not all) authors and treating physicians were responsive, resulting in incomplete data. ALCL lesions first presented as late peri-implant seromas, a mass attached to the capsule, tumor erosion through the skin, in a regional node, or discovered during revision surgery. The clinical course varied widely from a single positive cytology result followed by apparent spontaneous resolution, to disseminated treatment-resistant tumor and death. There was no preference for saline or silicone fill or for cosmetic or reconstructive indications. Where implant history was known, the patient had received at least one textured-surface device. Extracapsular dissemination occurred in 18 cases; nine of those were fatal. Histochemical markers were primarily CD-30 and Alk-1. Other markers occurred at a lower frequency. Risk estimates ranged from one in 500,000 to one in 3 million women with implants. Breast implant-associated ALCL is a novel manifestation of site- and material-specific lymphoma originating in a specific scar location, presenting a wide array of diverse characteristics and suggesting a multifactorial cause.
              Article 0 comments Cited 121 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Journal
                Journal ID (iso-abbrev): Plast. Reconstr. Surg.
                Title: Plastic and reconstructive surgery
                Publisher: Ovid Technologies (Wolters Kluwer Health)
                ISSN (Electronic): 1529-4242
                ISSN (Print): 0032-1052
                Publication date (Electronic): May 2017
                Volume: 139
                Issue: 5
                Affiliations
                [1 ] Milwaukee, Wis.; and Houston, Texas From the Department of Plastic Surgery, Medical College of Wisconsin, Tosa Center; and the Departments of Hematopathology and Plastic Surgery, The University of Texas M. D. Anderson Cancer Center.
                Article
                DOI: 10.1097/PRS.0000000000003282
                PubMed ID: 28157769
                SO-VID: e29d5c88-2670-48a2-8ab6-80fa9e2ecaee
                History

                Data availability:

                Comments

                Comment on this article

                scite_

                Similar content1,037

                See all similar

                Cited by101

                See all cited by

                Most referenced authors313

                See all reference authors